NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED) Medication Singapore | Medicine SG

NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED) is a medication in Singapore. The dosage in INJECTION, SUSPENSION form, is administered by the INTRAMUSCULAR route. The licence is held by PHARMENG TECHNOLOGY PTE. LTD., approved on 1970-01-01, with the number SIN16886P. The forensic classification is Prescription Only, and ATC code is J07BN04.

Permalink: https://www.medicinesg.com/sg/meds/nuvaxovid-dispersion-for-injection-covid-19-vaccine-5-%c2%b5g-dose-recombinant-adjuvanted/

Licence number: SIN16886P
Product name: NUVAXOVID DISPERSION FOR INJECTION COVID-19 VACCINE 5 µg/dose (RECOMBINANT, ADJUVANTED)
License holder: PHARMENG TECHNOLOGY PTE. LTD.
Approval date: 1970-01-01
Forensic classification: Prescription Only
ATC Code: J07BN04
Dosage form: INJECTION, SUSPENSION
Route of Administration: INTRAMUSCULAR
Manufacturer & Country of manufacturer:
- Serum Institute Of India Private Limited – INDIA
Active ingredients & Strength:
- SARS-CoV-2 recombinant spike protein – 5 µg/dose